From: Patient outcomes following AKI and AKD: a population-based cohort study
Definition | Description |
---|---|
Baseline serum creatinine (SCr) | |
 Reference value 1 (RV1) | Lowest value of: • Median of the SCr levels in the 8 to 365 days prior to the index date • Lowest of the SCr levels in the 1 to 7 days prior to the index date |
 Reference value 2 (RV2) | Lowest value of the SCr levels in the 1 to 2 days (48 h) prior to the index date |
AKI identification | |
 By SCr ratio | Index SCr ≥ 1.5 times higher than RV1 |
 By SCr increment | Index SCr <  1.5 times higher than RV1; but ≥26.5 μmol/L higher than RV2 |
AKI stage | |
 Stage 1 | Index SCr/RV1 ≥ 1.5 and <  2; or Index SCr – RV2 ≥ 26.5 μmol/L |
 Stage 2 | Index SCr/RV1 ≥ 2 and <  3 |
 Stage 3 | Index SCr/RV1 ≥ 3; or Index SCr ≥ 353.6 μmol/L |
AKI category | |
 Community-acquired/community-managed AKI | AKI diagnosed in the community and not admitted to hospital within 7 days |
 Community-acquired/hospital-managed AKI | Either of the following: • AKI developed in the community and admitted to hospital within 7 days • AKI presented in the first 2 days in hospital, i.e. day 0 (admission) + day 1 |
 Hospital-acquired AKI | AKI developed on or after 2 days in hospital, i.e. from day 2 onwards |
Patient status at day 7 and day 90 following the AKI episode | |
 Creatinine-recovery | Patient recovered, did not die and did not initiate chronic KRT during the period considered |
 No creatinine-recovery | Patient did not recover, did not die and did not initiate chronic KRT during the period considered |
 Death | Patient died during the period considered |
 KRT | Patient initiated KRT during the period considered |
 Untested | Patient was not tested, did not die and did not initiate chronic KRT during the period considered |